SCHEMBL29564372

SCHEMBL29564372

N#Cc1cccc(NCc2ccccc2)c1N1C(=O)CCCC1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.56
HPGD P15428 3/20 0.56
HSD17B10 Q99714 2/20 0.56
TSHR P16473 2/20 0.56
HTR2A P28223 1/20 0.41
HTR6 P50406 1/20 0.41
BCL2 P10415 1/20 0.41
MAPK1 P28482 2/20 0.41
POLB P06746 2/20 0.40
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
PRKACA P17612 1/20 0.39
CDK8 P49336 1/20 0.39
CLK2 P49760 1/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
CDK9 P50750 1/20 0.39
CDK5 Q00535 1/20 0.39
PRKCQ Q04759 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22273612 0.75 KDM4E (0.42) KDM4EHPGDHSD17B10TSHRHTR2A
SCHEMBL3475619 0.73 KDM4E (1.00) KDM4EHPGDHSD17B10TSHRHTR2A
SCHEMBL10330188 0.71 KDM4E (0.75) KDM4EHPGDHSD17B10TSHRHTR2A
SCHEMBL29456651 0.70 KDM4E (0.73) KDM4EHPGDHSD17B10TSHRHTR2A
SCHEMBL29564375 0.67 KDM4E (0.44) KDM4EHPGDHSD17B10TSHRLRRK2
SCHEMBL13447402 0.66 RXRA (0.72) KDM4EHPGDHSD17B10TSHRPOLB
SCHEMBL5123728 0.64 RXRA (0.51) KDM4EHPGDHSD17B10TSHRPOLB
SCHEMBL4389194 0.63 POLB (0.47) HSD17B10POLBGSK3AGSK3BL3MBTL1
SCHEMBL28873028 0.63 KDM4E (0.75) KDM4EHPGDHSD17B10TSHRHTR2A
SCHEMBL29152740 0.63 MAPK1 (0.55) KDM4EHPGDHSD17B10TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109651297-B N-benzyl-N-aryl sulfonamide derivative and preparation and application thereof 杭州壹瑞医药科技有限公司 2022-05-27 CN disclosed